Beta-Blockers [phsu]
PREVENT [phsu]
Stroke [dsyn]
Recurrence [phpr]
Background [cnce]
Stroke [dsyn]
Affect [menp]
Million [qnco]
People [popg]
Recent [tmco]
development [phsf]
Stroke, Acute [dsyn]
treatment [ftcn]
Prevention [topp]
Very [qlco]
Stroke [dsyn]
High [qlco]
Rate [acty]
Recurrence [phpr]
Secondary Prevention [topp]
Clinical [qlco]
Approaches [spco]
Control [grup]
risk factors [qnco]
PROPOSED [idcn]
One [qnco]
Approaches [spco]
Prescription [hlca]
Beta-Blockers [phsu]
effects [qlco]
reduction [npop]
Blood Pressure [orgf]
Recurrence [phpr]
Stroke [dsyn]
objectives [inpr]
To [qlco]
Evaluate [ftcn]
Efficacy [qlco]
Beta-Blockers [phsu]
PREVENT [phsu]
Stroke [dsyn]
Recurrence [phpr]
Reducing [qlco]
Death [orgf]
Major [qlco]
vascular [bpoc]
Events [evnt]
People [popg]
Previous [tmco]
Stroke [dsyn]
Transient Ischemic Attack [dsyn]
To [qlco]
Safety [hcpp]
development [phsf]
Diabetes Mellitus [dsyn]
search [inpr]
Methods [inpr]
Searched [acty]
Stroke [dsyn]
Group [idcn]
Trial [resa]
Central [spco]
Controlled [ftcn]
Trial [resa]
Database [inpr]
Review, Systematic [inpr]
Library [mnob, orgt]
Issue [fndg]
Database [inpr]
Abstracts [inpr]
reviews [inpr]
effects [qlco]
MEDLINE [inpr]
Latin American [popg]
Caribbean [geoa]
Health Sciences [bmod]
Literature [inpr]
lilacs [plnt]
Searched [acty]
ONGOING [idcn]
Trial [resa]
Registers [inpr]
Reference [idcn]
List [cnce]
Selection Criteria [qlco]
Controlled [ftcn]
Trial [resa]
included [ftcn]
participants [popg]
Previous [tmco]
Stroke [dsyn]
Transient Ischemic Attack [dsyn]
Arterial thrombosis [dsyn]
Embolism [patf]
intervention [hlca]
Beta-blocker [phsu]
Control [grup]
Beta-blocker [phsu]
treatment [ftcn]
treatment [ftcn]
Data Collection [resa]
Analysis [lbpr]
Two [qnco]
Review [inpr]
Authors [prog]
screen [hlca]
Trial [resa]
Identified [qlco]
Quality [qlco]
Extracted [topp]
Data [idcn]
Main [qlco]
Result [ftcn]
included [ftcn]
Two [qnco]
Controlled [ftcn]
Trial [resa]
Involving [ftcn]
participants [popg]
Review [inpr]
Study [mnob]
participants [popg]
Beta-blocker [phsu]
Atenolol [orch, phsu]
mg% [qnco]
placebo [topp]
High [qlco]
methodology [inpr]
Quality [qlco]
Note [clna]
Statistical [ocdi]
Group [idcn]
Risks [qlco]
Fatal [qlco]
Non [ftcn]
Fatal [qlco]
Stroke risk [inpr]
Ratio [qnco]
Confidence Interval [qnco]
Outcome [ftcn]
Major [qlco]
vascular [bpoc]
Events [evnt]
Death [orgf]
Death [orgf]
CARDIOVASCULAR [bdsy]
Observed [ftcn]
Group [idcn]
Minor [popg]
Blood Pressure [orgf]
reductions [npop]
Intervention Group [popg]
included [ftcn]
studies [lbpr]
Reported [inpr]
occurrence [ftcn]
Diabetes [dsyn]
Outcome [ftcn]
Assessed [acty]
Quality [qlco]
Life [idcn]
adverse events [fndg]
Frequent [tmco]
participants [popg]
Take [hlca]
Atenolol [orch, phsu]
GIVEN [cnce]
placebo [topp]
Most [qnco]
Common [qnco]
Reason [idcn]
GIVEN [cnce]
Discontinue [fndg]
treatment [ftcn]
Risk Ratio [qnco]
Confidence Interval [qnco]
Authors [prog]
Conclusions [idcn]
Date [tmco]
Available [ftcn]
Evidence [ftcn]
Support [medd]
Routine [qlco]
Beta-Blockers [phsu]
Secondary Prevention [topp]
Stroke [dsyn]
Transient Ischemic Attack [dsyn]
More [ftcn]
Study [mnob]
larger [qnco]
Sample [sbst]
Needed [qlco]
